The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Bohas, C. L., Wolin, E. M., Van Cutsem, E., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,876
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Raymond, E., Dahan, L., Raoul, J.-L., Bang, Y.-J., Borbath, I., Lombard-Bohas, C., Valle, J., Metrakos, P., Smith, D., Vinik, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003825 · Cited by 2,567
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,717
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Heaphy, C. M., de Wilde, R. F., Jiao, Y., Klein, A. P., Edil, B. H., Shi, C., Bettegowda, C., Rodriguez, F. J., Eberhart, C. G., Hebbar, S., et al. (2011) · Science · doi:10.1126/science.1207313 · Cited by 1,083 · cited 1×
“CLICAL PACREAS Both DAXX and ATRX mutations in pNETs are associated with alternative lengthening of telomere (ALT) activation.(9) This phenotype is rarely observed in other types of carcinomas and never in pNETs with DAXX and ATRX expression.”
MethodTelomeres: protecting chromosomes against genome instability
O'Sullivan, R. J., & Karlseder, J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2848 · Cited by 996
Strosberg, J. R., Fine, R. L., Choi, J., Nasir, A., Coppola, D., Chen, D., Helm, J., & Kvols, L. (2011) · Cancer · doi:10.1002/cncr.25425 · Cited by 766
Lovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H. J., Sung, P. A., Jasin, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002772 · Cited by 629
Yachida, S., Vakiani, E., White, C. M., Zhong, Y., Saunders, T., Morgan, R., de Wilde, R. F., Maitra, A., Hicks, J., DeMarzo, A. M., et al. (2012) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182417d36 · Cited by 534
Heaphy, C. M., Subhawong, A. P., Hong, S.-M., Goggins, M. G., Montgomery, E. A., Gabrielson, E., Netto, G. J., Epstein, J. I., Lotan, T. L., Westra, W. H., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.018 · Cited by 516
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
Halfdanarson, T. R., Rubin, J., Farnell, M. B., Grant, C. S., & Petersen, G. M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0221 · Cited by 372
DAXX envelops a histone H3.3–H4 dimer for H3.3-specific recognition
Elsässer, S. J., Huang, H., Lewis, P. W., Chin, J. W., Allis, C. D., & Patel, D. J. (2012) · Nature · doi:10.1038/nature11608 · Cited by 251
Daxx: death or survival protein?
Salomoni, P., & Khelifi, A. F. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.12.002 · Cited by 190
Speel, E. J. M., Richter, J., Moch, H., Egenter, C., Saremaslani, P., Rütimann, K., Zhao, J., Barghorn, A., Roth, J., Heitz, P. U., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65495-8 · Cited by 162
Self-citationRigaud, G., Missiaglia, E., Moore, P. S., Zamboni, G., Falconi, M., Talamini, G., Pesci, A., Baron, A., Lissandrini, D., Rindi, G., et al. (2001) · PubMed · Cited by 150
WHO 2004 Criteria and CK19 are Reliable Prognostic Markers in Pancreatic Endocrine Tumors
Schmitt, A. M., Anlauf, M., Rousson, V., Schmid, S., Kofler, A., Riniker, F., Bauersfeld, J., Barghorn, A., Probst-Hensch, N. M., Moch, H., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31805f675d · Cited by 148
Self-citationWell-differentiated pancreatic neuroendocrine tumors: from genetics to therapy
de Wilde, R. F., Edil, B. H., Hruban, R. H., & Maitra, A. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.9 · Cited by 122
Compromised genomic integrity impedes muscle growth after Atrx inactivation
Huh, M. S., O’Dea, T. P., Ouazia, D., McKay, B. C., Parise, G., Parks, R. J., Rudnicki, M. A., & Picketts, D. J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63765 · Cited by 71
Loss of Atrx Sensitizes Cells to DNA Damaging Agents through p53-Mediated Death Pathways
Conte, D., Huh, M. S., Goodall, E. C., Delorme, M., Parks, R. J., & Picketts, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052167 · Cited by 44
Molecular alterations during insulinoma tumorigenesis
Versleijen‐Jonkers, Y. M. H., Ramaekers, F. C. S., & Speel, E. M. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.004 · Cited by 44
Self-citationLundberg, G., Sehic, D., Länsberg, J., Øra, I., Frigyesi, A., Castel, V., Navarro, S., Piqueras, M., Martinsson, T., Noguera, R., et al. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20850 · Cited by 43
Telomere lengthening in telomerase-negative cells: the ends are coming together
Scheel, C., & Poremba, C. (2002) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-002-0634-9 · Cited by 32
Versleijen‐Jonkers, Y. M. H., Claessen, S. M. H., Feuth, T., van Kessel, A. G., Ramaekers, F. C. S., Veltman, J. A., & Speel, E. M. (2006) · The Journal of Pathology · doi:10.1002/path.2072 · Cited by 32
Self-citationVersleijen‐Jonkers, Y. M. H., Claessen, S. M. H., Veltman, J. A., van Kessel, A. G., Dinjens, W. N. M., Skogseid, B. M., Ramaekers, F. C. S., & Speel, E. M. (2006) · Cytogenetic and Genome Research · doi:10.1159/000095926 · Cited by 27
Self-citationBollmann, F. M. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.08.006 · Cited by 23
Pan, W., Yi, F., Cao, L.-X., Liu, X., Shen, Z., Bu, Y., Xu, Y., Fan, H., & Song, F. (2013) · Gene · doi:10.1016/j.gene.2013.03.103 · Cited by 19
Genomic instability is associated with lack of telomerase activation in ovarian cancer
Landen, C. N., Klingelhutz, A. J., Coffin, J. E., Sorosky, J. I., & Sood, A. K. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.12.1235 · Cited by 16
Molecular alterations during insulinoma tumorigenesis
Versleijen‐Jonkers, Y. M. H. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20070614yj · Cited by 14
Cited by
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
Rindi, G., Mete, O., Uccella, S., Basturk, O., La Rosa, S., Brosens, L. A. A., Ezzat, S., de Herder, W. W., Klimstra, D. S., Papotti, M., et al. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09708-2 · Cited by 1,036
Whole-genome landscape of pancreatic neuroendocrine tumours
Initiative, A. P. C. G., Scarpa, A., Chang, D. K., Nones, K., Corbo, V., Patch, A.-M., Bailey, P., Lawlor, R. T., Johns, A. L., Miller, D. K., et al. (2017) · Nature · doi:10.1038/nature21063 · Cited by 999
Gastroenteropancreatic Neuroendocrine Tumors
Cives, M., & Strosberg, J. R. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21493 · Cited by 586
Gopal, R. K., Kübler, K., Calvo, S. E., Polak, P., Livitz, D., Rosebrock, D., Sadow, P. M., Campbell, B., Donovan, S. E., Amin, S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.013 · Cited by 263
Metadata
- Authors
- Marinoni, I., Kurrer, A. S., Vassella, E., Dettmer, M., Rudolph, T., Banz, V., Hunger, F., Pasquinelli, S., Speel, E., & Perren, A.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 146
- Issue
- 2
- Pages
- 453-460.e5
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2171342611
- Cited by
- 463
- References
- 29
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.